Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) has been given an average recommendation of “Hold” by the six research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $45.50.
Several equities analysts recently weighed in on the stock. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Piper Sandler dropped their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Stifel Nicolaus reduced their target price on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Finally, Cantor Fitzgerald decreased their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th.
View Our Latest Stock Analysis on TRUP
Insider Buying and Selling at Trupanion
Institutional Investors Weigh In On Trupanion
Large investors have recently added to or reduced their stakes in the company. Voya Investment Management LLC increased its stake in shares of Trupanion by 2.4% in the third quarter. Voya Investment Management LLC now owns 10,379 shares of the financial services provider’s stock worth $449,000 after purchasing an additional 243 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Trupanion by 3.5% during the 2nd quarter. Bank of Montreal Can now owns 7,280 shares of the financial services provider’s stock valued at $403,000 after buying an additional 245 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in Trupanion by 1.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after buying an additional 282 shares during the period. EP Wealth Advisors LLC boosted its holdings in Trupanion by 2.9% in the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after buying an additional 292 shares during the period. Finally, New York State Common Retirement Fund grew its stake in Trupanion by 0.4% in the 2nd quarter. New York State Common Retirement Fund now owns 83,930 shares of the financial services provider’s stock valued at $4,646,000 after buying an additional 296 shares in the last quarter.
Trupanion Stock Performance
Shares of Trupanion stock opened at $25.51 on Friday. The business’s fifty day simple moving average is $29.89 and its 200 day simple moving average is $36.60. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. Trupanion has a 12 month low of $24.32 and a 12 month high of $57.88. The firm has a market capitalization of $1.11 billion, a P/E ratio of 56.69 and a beta of 1.62.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. During the same quarter last year, the company earned $0.04 EPS. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. As a group, analysts anticipate that Trupanion will post 0.13 EPS for the current year.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
